Global Hyperthyroidism Medications Supply, Demand and Key Producers, 2023-2029
The global Hyperthyroidism Medications market size is expected to reach $ 699.6 million by 2029, rising at a market growth of 6.0% CAGR during the forecast period (2023-2029).
Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
This report studies the global Hyperthyroidism Medications production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hyperthyroidism Medications, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperthyroidism Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hyperthyroidism Medications total production and demand, 2018-2029, (K Units)
Global Hyperthyroidism Medications total production value, 2018-2029, (USD Million)
Global Hyperthyroidism Medications production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperthyroidism Medications consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hyperthyroidism Medications domestic production, consumption, key domestic manufacturers and share
Global Hyperthyroidism Medications production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hyperthyroidism Medications market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical and Zibo Wankang Pharmaceutical Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperthyroidism Medications market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hyperthyroidism Medications Market, By Region:
1. How big is the global Hyperthyroidism Medications market?
2. What is the demand of the global Hyperthyroidism Medications market?
3. What is the year over year growth of the global Hyperthyroidism Medications market?
4. What is the production and production value of the global Hyperthyroidism Medications market?
5. Who are the key producers in the global Hyperthyroidism Medications market?
6. What are the growth factors driving the market demand?
Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
This report studies the global Hyperthyroidism Medications production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hyperthyroidism Medications, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperthyroidism Medications that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hyperthyroidism Medications total production and demand, 2018-2029, (K Units)
Global Hyperthyroidism Medications total production value, 2018-2029, (USD Million)
Global Hyperthyroidism Medications production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperthyroidism Medications consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hyperthyroidism Medications domestic production, consumption, key domestic manufacturers and share
Global Hyperthyroidism Medications production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperthyroidism Medications production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Hyperthyroidism Medications market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical and Zibo Wankang Pharmaceutical Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperthyroidism Medications market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Hyperthyroidism Medications Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Methimazole
- Propylthiouracil
- Other
- Hospital
- Clinic
- Other
- Merck
- Herbrand PharmaChemicals
- Shanghai Zhaohui Pharmaceutical
- Beijing Yanjing Pharmaceutical
- Jinghua Pharmaceutical Group
- Guangzhou Kanghe Pharmaceutical
- Zigong Honghe Pharmaceutical
- Guangdong Huanan Pharmaceutical
- Zibo Wankang Pharmaceutical Chemical
- Qilu Pharmaceutical
1. How big is the global Hyperthyroidism Medications market?
2. What is the demand of the global Hyperthyroidism Medications market?
3. What is the year over year growth of the global Hyperthyroidism Medications market?
4. What is the production and production value of the global Hyperthyroidism Medications market?
5. Who are the key producers in the global Hyperthyroidism Medications market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Hyperthyroidism Medications Introduction
1.2 World Hyperthyroidism Medications Supply & Forecast
1.2.1 World Hyperthyroidism Medications Production Value (2018 & 2022 & 2029)
1.2.2 World Hyperthyroidism Medications Production (2018-2029)
1.2.3 World Hyperthyroidism Medications Pricing Trends (2018-2029)
1.3 World Hyperthyroidism Medications Production by Region (Based on Production Site)
1.3.1 World Hyperthyroidism Medications Production Value by Region (2018-2029)
1.3.2 World Hyperthyroidism Medications Production by Region (2018-2029)
1.3.3 World Hyperthyroidism Medications Average Price by Region (2018-2029)
1.3.4 North America Hyperthyroidism Medications Production (2018-2029)
1.3.5 Europe Hyperthyroidism Medications Production (2018-2029)
1.3.6 China Hyperthyroidism Medications Production (2018-2029)
1.3.7 Japan Hyperthyroidism Medications Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hyperthyroidism Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hyperthyroidism Medications Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hyperthyroidism Medications Demand (2018-2029)
2.2 World Hyperthyroidism Medications Consumption by Region
2.2.1 World Hyperthyroidism Medications Consumption by Region (2018-2023)
2.2.2 World Hyperthyroidism Medications Consumption Forecast by Region (2024-2029)
2.3 United States Hyperthyroidism Medications Consumption (2018-2029)
2.4 China Hyperthyroidism Medications Consumption (2018-2029)
2.5 Europe Hyperthyroidism Medications Consumption (2018-2029)
2.6 Japan Hyperthyroidism Medications Consumption (2018-2029)
2.7 South Korea Hyperthyroidism Medications Consumption (2018-2029)
2.8 ASEAN Hyperthyroidism Medications Consumption (2018-2029)
2.9 India Hyperthyroidism Medications Consumption (2018-2029)
3 WORLD HYPERTHYROIDISM MEDICATIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hyperthyroidism Medications Production Value by Manufacturer (2018-2023)
3.2 World Hyperthyroidism Medications Production by Manufacturer (2018-2023)
3.3 World Hyperthyroidism Medications Average Price by Manufacturer (2018-2023)
3.4 Hyperthyroidism Medications Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hyperthyroidism Medications Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hyperthyroidism Medications in 2022
3.5.3 Global Concentration Ratios (CR8) for Hyperthyroidism Medications in 2022
3.6 Hyperthyroidism Medications Market: Overall Company Footprint Analysis
3.6.1 Hyperthyroidism Medications Market: Region Footprint
3.6.2 Hyperthyroidism Medications Market: Company Product Type Footprint
3.6.3 Hyperthyroidism Medications Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hyperthyroidism Medications Production Value Comparison
4.1.1 United States VS China: Hyperthyroidism Medications Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hyperthyroidism Medications Production Comparison
4.2.1 United States VS China: Hyperthyroidism Medications Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hyperthyroidism Medications Consumption Comparison
4.3.1 United States VS China: Hyperthyroidism Medications Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hyperthyroidism Medications Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
4.5 China Based Hyperthyroidism Medications Manufacturers and Market Share
4.5.1 China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.5.3 China Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
4.6 Rest of World Based Hyperthyroidism Medications Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hyperthyroidism Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Methimazole
5.2.2 Propylthiouracil
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Hyperthyroidism Medications Production by Type (2018-2029)
5.3.2 World Hyperthyroidism Medications Production Value by Type (2018-2029)
5.3.3 World Hyperthyroidism Medications Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hyperthyroidism Medications Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hyperthyroidism Medications Production by Application (2018-2029)
6.3.2 World Hyperthyroidism Medications Production Value by Application (2018-2029)
6.3.3 World Hyperthyroidism Medications Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Hyperthyroidism Medications Product and Services
7.1.4 Merck Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Herbrand PharmaChemicals
7.2.1 Herbrand PharmaChemicals Details
7.2.2 Herbrand PharmaChemicals Major Business
7.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
7.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Herbrand PharmaChemicals Recent Developments/Updates
7.2.6 Herbrand PharmaChemicals Competitive Strengths & Weaknesses
7.3 Shanghai Zhaohui Pharmaceutical
7.3.1 Shanghai Zhaohui Pharmaceutical Details
7.3.2 Shanghai Zhaohui Pharmaceutical Major Business
7.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
7.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
7.3.6 Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
7.4 Beijing Yanjing Pharmaceutical
7.4.1 Beijing Yanjing Pharmaceutical Details
7.4.2 Beijing Yanjing Pharmaceutical Major Business
7.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
7.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
7.4.6 Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
7.5 Jinghua Pharmaceutical Group
7.5.1 Jinghua Pharmaceutical Group Details
7.5.2 Jinghua Pharmaceutical Group Major Business
7.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
7.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
7.5.6 Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
7.6 Guangzhou Kanghe Pharmaceutical
7.6.1 Guangzhou Kanghe Pharmaceutical Details
7.6.2 Guangzhou Kanghe Pharmaceutical Major Business
7.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
7.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
7.6.6 Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
7.7 Zigong Honghe Pharmaceutical
7.7.1 Zigong Honghe Pharmaceutical Details
7.7.2 Zigong Honghe Pharmaceutical Major Business
7.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
7.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
7.7.6 Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
7.8 Guangdong Huanan Pharmaceutical
7.8.1 Guangdong Huanan Pharmaceutical Details
7.8.2 Guangdong Huanan Pharmaceutical Major Business
7.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
7.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
7.8.6 Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
7.9 Zibo Wankang Pharmaceutical Chemical
7.9.1 Zibo Wankang Pharmaceutical Chemical Details
7.9.2 Zibo Wankang Pharmaceutical Chemical Major Business
7.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
7.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
7.9.6 Zibo Wankang Pharmaceutical Chemical Competitive Strengths & Weaknesses
7.10 Qilu Pharmaceutical
7.10.1 Qilu Pharmaceutical Details
7.10.2 Qilu Pharmaceutical Major Business
7.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
7.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Qilu Pharmaceutical Recent Developments/Updates
7.10.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hyperthyroidism Medications Industry Chain
8.2 Hyperthyroidism Medications Upstream Analysis
8.2.1 Hyperthyroidism Medications Core Raw Materials
8.2.2 Main Manufacturers of Hyperthyroidism Medications Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hyperthyroidism Medications Production Mode
8.6 Hyperthyroidism Medications Procurement Model
8.7 Hyperthyroidism Medications Industry Sales Model and Sales Channels
8.7.1 Hyperthyroidism Medications Sales Model
8.7.2 Hyperthyroidism Medications Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Hyperthyroidism Medications Introduction
1.2 World Hyperthyroidism Medications Supply & Forecast
1.2.1 World Hyperthyroidism Medications Production Value (2018 & 2022 & 2029)
1.2.2 World Hyperthyroidism Medications Production (2018-2029)
1.2.3 World Hyperthyroidism Medications Pricing Trends (2018-2029)
1.3 World Hyperthyroidism Medications Production by Region (Based on Production Site)
1.3.1 World Hyperthyroidism Medications Production Value by Region (2018-2029)
1.3.2 World Hyperthyroidism Medications Production by Region (2018-2029)
1.3.3 World Hyperthyroidism Medications Average Price by Region (2018-2029)
1.3.4 North America Hyperthyroidism Medications Production (2018-2029)
1.3.5 Europe Hyperthyroidism Medications Production (2018-2029)
1.3.6 China Hyperthyroidism Medications Production (2018-2029)
1.3.7 Japan Hyperthyroidism Medications Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Hyperthyroidism Medications Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Hyperthyroidism Medications Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Hyperthyroidism Medications Demand (2018-2029)
2.2 World Hyperthyroidism Medications Consumption by Region
2.2.1 World Hyperthyroidism Medications Consumption by Region (2018-2023)
2.2.2 World Hyperthyroidism Medications Consumption Forecast by Region (2024-2029)
2.3 United States Hyperthyroidism Medications Consumption (2018-2029)
2.4 China Hyperthyroidism Medications Consumption (2018-2029)
2.5 Europe Hyperthyroidism Medications Consumption (2018-2029)
2.6 Japan Hyperthyroidism Medications Consumption (2018-2029)
2.7 South Korea Hyperthyroidism Medications Consumption (2018-2029)
2.8 ASEAN Hyperthyroidism Medications Consumption (2018-2029)
2.9 India Hyperthyroidism Medications Consumption (2018-2029)
3 WORLD HYPERTHYROIDISM MEDICATIONS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Hyperthyroidism Medications Production Value by Manufacturer (2018-2023)
3.2 World Hyperthyroidism Medications Production by Manufacturer (2018-2023)
3.3 World Hyperthyroidism Medications Average Price by Manufacturer (2018-2023)
3.4 Hyperthyroidism Medications Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Hyperthyroidism Medications Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Hyperthyroidism Medications in 2022
3.5.3 Global Concentration Ratios (CR8) for Hyperthyroidism Medications in 2022
3.6 Hyperthyroidism Medications Market: Overall Company Footprint Analysis
3.6.1 Hyperthyroidism Medications Market: Region Footprint
3.6.2 Hyperthyroidism Medications Market: Company Product Type Footprint
3.6.3 Hyperthyroidism Medications Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Hyperthyroidism Medications Production Value Comparison
4.1.1 United States VS China: Hyperthyroidism Medications Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Hyperthyroidism Medications Production Comparison
4.2.1 United States VS China: Hyperthyroidism Medications Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Hyperthyroidism Medications Consumption Comparison
4.3.1 United States VS China: Hyperthyroidism Medications Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Hyperthyroidism Medications Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.4.3 United States Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
4.5 China Based Hyperthyroidism Medications Manufacturers and Market Share
4.5.1 China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.5.3 China Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
4.6 Rest of World Based Hyperthyroidism Medications Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Hyperthyroidism Medications Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Hyperthyroidism Medications Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Hyperthyroidism Medications Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Methimazole
5.2.2 Propylthiouracil
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Hyperthyroidism Medications Production by Type (2018-2029)
5.3.2 World Hyperthyroidism Medications Production Value by Type (2018-2029)
5.3.3 World Hyperthyroidism Medications Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Hyperthyroidism Medications Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Hyperthyroidism Medications Production by Application (2018-2029)
6.3.2 World Hyperthyroidism Medications Production Value by Application (2018-2029)
6.3.3 World Hyperthyroidism Medications Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Hyperthyroidism Medications Product and Services
7.1.4 Merck Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Herbrand PharmaChemicals
7.2.1 Herbrand PharmaChemicals Details
7.2.2 Herbrand PharmaChemicals Major Business
7.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
7.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Herbrand PharmaChemicals Recent Developments/Updates
7.2.6 Herbrand PharmaChemicals Competitive Strengths & Weaknesses
7.3 Shanghai Zhaohui Pharmaceutical
7.3.1 Shanghai Zhaohui Pharmaceutical Details
7.3.2 Shanghai Zhaohui Pharmaceutical Major Business
7.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
7.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
7.3.6 Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
7.4 Beijing Yanjing Pharmaceutical
7.4.1 Beijing Yanjing Pharmaceutical Details
7.4.2 Beijing Yanjing Pharmaceutical Major Business
7.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
7.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
7.4.6 Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
7.5 Jinghua Pharmaceutical Group
7.5.1 Jinghua Pharmaceutical Group Details
7.5.2 Jinghua Pharmaceutical Group Major Business
7.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
7.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
7.5.6 Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
7.6 Guangzhou Kanghe Pharmaceutical
7.6.1 Guangzhou Kanghe Pharmaceutical Details
7.6.2 Guangzhou Kanghe Pharmaceutical Major Business
7.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
7.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
7.6.6 Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
7.7 Zigong Honghe Pharmaceutical
7.7.1 Zigong Honghe Pharmaceutical Details
7.7.2 Zigong Honghe Pharmaceutical Major Business
7.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
7.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
7.7.6 Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
7.8 Guangdong Huanan Pharmaceutical
7.8.1 Guangdong Huanan Pharmaceutical Details
7.8.2 Guangdong Huanan Pharmaceutical Major Business
7.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
7.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
7.8.6 Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
7.9 Zibo Wankang Pharmaceutical Chemical
7.9.1 Zibo Wankang Pharmaceutical Chemical Details
7.9.2 Zibo Wankang Pharmaceutical Chemical Major Business
7.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
7.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
7.9.6 Zibo Wankang Pharmaceutical Chemical Competitive Strengths & Weaknesses
7.10 Qilu Pharmaceutical
7.10.1 Qilu Pharmaceutical Details
7.10.2 Qilu Pharmaceutical Major Business
7.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
7.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Qilu Pharmaceutical Recent Developments/Updates
7.10.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Hyperthyroidism Medications Industry Chain
8.2 Hyperthyroidism Medications Upstream Analysis
8.2.1 Hyperthyroidism Medications Core Raw Materials
8.2.2 Main Manufacturers of Hyperthyroidism Medications Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Hyperthyroidism Medications Production Mode
8.6 Hyperthyroidism Medications Procurement Model
8.7 Hyperthyroidism Medications Industry Sales Model and Sales Channels
8.7.1 Hyperthyroidism Medications Sales Model
8.7.2 Hyperthyroidism Medications Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Hyperthyroidism Medications Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hyperthyroidism Medications Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hyperthyroidism Medications Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hyperthyroidism Medications Production Value Market Share by Region (2018-2023)
Table 5. World Hyperthyroidism Medications Production Value Market Share by Region (2024-2029)
Table 6. World Hyperthyroidism Medications Production by Region (2018-2023) & (K Units)
Table 7. World Hyperthyroidism Medications Production by Region (2024-2029) & (K Units)
Table 8. World Hyperthyroidism Medications Production Market Share by Region (2018-2023)
Table 9. World Hyperthyroidism Medications Production Market Share by Region (2024-2029)
Table 10. World Hyperthyroidism Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hyperthyroidism Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hyperthyroidism Medications Major Market Trends
Table 13. World Hyperthyroidism Medications Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hyperthyroidism Medications Consumption by Region (2018-2023) & (K Units)
Table 15. World Hyperthyroidism Medications Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hyperthyroidism Medications Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hyperthyroidism Medications Producers in 2022
Table 18. World Hyperthyroidism Medications Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hyperthyroidism Medications Producers in 2022
Table 20. World Hyperthyroidism Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hyperthyroidism Medications Company Evaluation Quadrant
Table 22. World Hyperthyroidism Medications Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hyperthyroidism Medications Production Site of Key Manufacturer
Table 24. Hyperthyroidism Medications Market: Company Product Type Footprint
Table 25. Hyperthyroidism Medications Market: Company Product Application Footprint
Table 26. Hyperthyroidism Medications Competitive Factors
Table 27. Hyperthyroidism Medications New Entrant and Capacity Expansion Plans
Table 28. Hyperthyroidism Medications Mergers & Acquisitions Activity
Table 29. United States VS China Hyperthyroidism Medications Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hyperthyroidism Medications Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hyperthyroidism Medications Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 37. China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 42. Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 47. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Hyperthyroidism Medications Production by Type (2018-2023) & (K Units)
Table 49. World Hyperthyroidism Medications Production by Type (2024-2029) & (K Units)
Table 50. World Hyperthyroidism Medications Production Value by Type (2018-2023) & (USD Million)
Table 51. World Hyperthyroidism Medications Production Value by Type (2024-2029) & (USD Million)
Table 52. World Hyperthyroidism Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Hyperthyroidism Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hyperthyroidism Medications Production by Application (2018-2023) & (K Units)
Table 56. World Hyperthyroidism Medications Production by Application (2024-2029) & (K Units)
Table 57. World Hyperthyroidism Medications Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hyperthyroidism Medications Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hyperthyroidism Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hyperthyroidism Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Hyperthyroidism Medications Product and Services
Table 64. Merck Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Herbrand PharmaChemicals Basic Information, Manufacturing Base and Competitors
Table 68. Herbrand PharmaChemicals Major Business
Table 69. Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
Table 70. Herbrand PharmaChemicals Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Herbrand PharmaChemicals Recent Developments/Updates
Table 72. Herbrand PharmaChemicals Competitive Strengths & Weaknesses
Table 73. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Zhaohui Pharmaceutical Major Business
Table 75. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
Table 76. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 78. Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Beijing Yanjing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Yanjing Pharmaceutical Major Business
Table 81. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
Table 82. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Yanjing Pharmaceutical Recent Developments/Updates
Table 84. Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Jinghua Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 86. Jinghua Pharmaceutical Group Major Business
Table 87. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
Table 88. Jinghua Pharmaceutical Group Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Jinghua Pharmaceutical Group Recent Developments/Updates
Table 90. Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
Table 91. Guangzhou Kanghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Guangzhou Kanghe Pharmaceutical Major Business
Table 93. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 94. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
Table 96. Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Zigong Honghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Zigong Honghe Pharmaceutical Major Business
Table 99. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 100. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zigong Honghe Pharmaceutical Recent Developments/Updates
Table 102. Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Guangdong Huanan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Guangdong Huanan Pharmaceutical Major Business
Table 105. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
Table 106. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Guangdong Huanan Pharmaceutical Recent Developments/Updates
Table 108. Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Zibo Wankang Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 110. Zibo Wankang Pharmaceutical Chemical Major Business
Table 111. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
Table 112. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
Table 114. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 115. Qilu Pharmaceutical Major Business
Table 116. Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
Table 117. Qilu Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Hyperthyroidism Medications Upstream (Raw Materials)
Table 119. Hyperthyroidism Medications Typical Customers
Table 120. Hyperthyroidism Medications Typical Distributors
Table 1. World Hyperthyroidism Medications Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Hyperthyroidism Medications Production Value by Region (2018-2023) & (USD Million)
Table 3. World Hyperthyroidism Medications Production Value by Region (2024-2029) & (USD Million)
Table 4. World Hyperthyroidism Medications Production Value Market Share by Region (2018-2023)
Table 5. World Hyperthyroidism Medications Production Value Market Share by Region (2024-2029)
Table 6. World Hyperthyroidism Medications Production by Region (2018-2023) & (K Units)
Table 7. World Hyperthyroidism Medications Production by Region (2024-2029) & (K Units)
Table 8. World Hyperthyroidism Medications Production Market Share by Region (2018-2023)
Table 9. World Hyperthyroidism Medications Production Market Share by Region (2024-2029)
Table 10. World Hyperthyroidism Medications Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Hyperthyroidism Medications Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Hyperthyroidism Medications Major Market Trends
Table 13. World Hyperthyroidism Medications Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Hyperthyroidism Medications Consumption by Region (2018-2023) & (K Units)
Table 15. World Hyperthyroidism Medications Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Hyperthyroidism Medications Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Hyperthyroidism Medications Producers in 2022
Table 18. World Hyperthyroidism Medications Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Hyperthyroidism Medications Producers in 2022
Table 20. World Hyperthyroidism Medications Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Hyperthyroidism Medications Company Evaluation Quadrant
Table 22. World Hyperthyroidism Medications Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Hyperthyroidism Medications Production Site of Key Manufacturer
Table 24. Hyperthyroidism Medications Market: Company Product Type Footprint
Table 25. Hyperthyroidism Medications Market: Company Product Application Footprint
Table 26. Hyperthyroidism Medications Competitive Factors
Table 27. Hyperthyroidism Medications New Entrant and Capacity Expansion Plans
Table 28. Hyperthyroidism Medications Mergers & Acquisitions Activity
Table 29. United States VS China Hyperthyroidism Medications Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Hyperthyroidism Medications Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Hyperthyroidism Medications Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 37. China Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 42. Rest of World Based Hyperthyroidism Medications Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Hyperthyroidism Medications Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Hyperthyroidism Medications Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share (2018-2023)
Table 47. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Hyperthyroidism Medications Production by Type (2018-2023) & (K Units)
Table 49. World Hyperthyroidism Medications Production by Type (2024-2029) & (K Units)
Table 50. World Hyperthyroidism Medications Production Value by Type (2018-2023) & (USD Million)
Table 51. World Hyperthyroidism Medications Production Value by Type (2024-2029) & (USD Million)
Table 52. World Hyperthyroidism Medications Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Hyperthyroidism Medications Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Hyperthyroidism Medications Production by Application (2018-2023) & (K Units)
Table 56. World Hyperthyroidism Medications Production by Application (2024-2029) & (K Units)
Table 57. World Hyperthyroidism Medications Production Value by Application (2018-2023) & (USD Million)
Table 58. World Hyperthyroidism Medications Production Value by Application (2024-2029) & (USD Million)
Table 59. World Hyperthyroidism Medications Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Hyperthyroidism Medications Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Hyperthyroidism Medications Product and Services
Table 64. Merck Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Herbrand PharmaChemicals Basic Information, Manufacturing Base and Competitors
Table 68. Herbrand PharmaChemicals Major Business
Table 69. Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
Table 70. Herbrand PharmaChemicals Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Herbrand PharmaChemicals Recent Developments/Updates
Table 72. Herbrand PharmaChemicals Competitive Strengths & Weaknesses
Table 73. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Zhaohui Pharmaceutical Major Business
Table 75. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
Table 76. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 78. Shanghai Zhaohui Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Beijing Yanjing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Yanjing Pharmaceutical Major Business
Table 81. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
Table 82. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Yanjing Pharmaceutical Recent Developments/Updates
Table 84. Beijing Yanjing Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Jinghua Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 86. Jinghua Pharmaceutical Group Major Business
Table 87. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
Table 88. Jinghua Pharmaceutical Group Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Jinghua Pharmaceutical Group Recent Developments/Updates
Table 90. Jinghua Pharmaceutical Group Competitive Strengths & Weaknesses
Table 91. Guangzhou Kanghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Guangzhou Kanghe Pharmaceutical Major Business
Table 93. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 94. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
Table 96. Guangzhou Kanghe Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Zigong Honghe Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Zigong Honghe Pharmaceutical Major Business
Table 99. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
Table 100. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Zigong Honghe Pharmaceutical Recent Developments/Updates
Table 102. Zigong Honghe Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Guangdong Huanan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Guangdong Huanan Pharmaceutical Major Business
Table 105. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
Table 106. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Guangdong Huanan Pharmaceutical Recent Developments/Updates
Table 108. Guangdong Huanan Pharmaceutical Competitive Strengths & Weaknesses
Table 109. Zibo Wankang Pharmaceutical Chemical Basic Information, Manufacturing Base and Competitors
Table 110. Zibo Wankang Pharmaceutical Chemical Major Business
Table 111. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
Table 112. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
Table 114. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 115. Qilu Pharmaceutical Major Business
Table 116. Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
Table 117. Qilu Pharmaceutical Hyperthyroidism Medications Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Hyperthyroidism Medications Upstream (Raw Materials)
Table 119. Hyperthyroidism Medications Typical Customers
Table 120. Hyperthyroidism Medications Typical Distributors
LIST OF FIGURES
Figure 1. Hyperthyroidism Medications Picture
Figure 2. World Hyperthyroidism Medications Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hyperthyroidism Medications Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 5. World Hyperthyroidism Medications Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hyperthyroidism Medications Production Value Market Share by Region (2018-2029)
Figure 7. World Hyperthyroidism Medications Production Market Share by Region (2018-2029)
Figure 8. North America Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 9. Europe Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 10. China Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 11. Japan Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 12. Hyperthyroidism Medications Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 15. World Hyperthyroidism Medications Consumption Market Share by Region (2018-2029)
Figure 16. United States Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 17. China Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 18. Europe Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 19. Japan Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 22. India Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hyperthyroidism Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hyperthyroidism Medications Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hyperthyroidism Medications Markets in 2022
Figure 26. United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 30. China Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 32. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hyperthyroidism Medications Production Value Market Share by Type in 2022
Figure 34. Methimazole
Figure 35. Propylthiouracil
Figure 36. Other
Figure 37. World Hyperthyroidism Medications Production Market Share by Type (2018-2029)
Figure 38. World Hyperthyroidism Medications Production Value Market Share by Type (2018-2029)
Figure 39. World Hyperthyroidism Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Hyperthyroidism Medications Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Hyperthyroidism Medications Production Market Share by Application (2018-2029)
Figure 46. World Hyperthyroidism Medications Production Value Market Share by Application (2018-2029)
Figure 47. World Hyperthyroidism Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Hyperthyroidism Medications Industry Chain
Figure 49. Hyperthyroidism Medications Procurement Model
Figure 50. Hyperthyroidism Medications Sales Model
Figure 51. Hyperthyroidism Medications Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Hyperthyroidism Medications Picture
Figure 2. World Hyperthyroidism Medications Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Hyperthyroidism Medications Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 5. World Hyperthyroidism Medications Average Price (2018-2029) & (US$/Unit)
Figure 6. World Hyperthyroidism Medications Production Value Market Share by Region (2018-2029)
Figure 7. World Hyperthyroidism Medications Production Market Share by Region (2018-2029)
Figure 8. North America Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 9. Europe Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 10. China Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 11. Japan Hyperthyroidism Medications Production (2018-2029) & (K Units)
Figure 12. Hyperthyroidism Medications Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 15. World Hyperthyroidism Medications Consumption Market Share by Region (2018-2029)
Figure 16. United States Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 17. China Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 18. Europe Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 19. Japan Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 20. South Korea Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 22. India Hyperthyroidism Medications Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Hyperthyroidism Medications by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Hyperthyroidism Medications Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Hyperthyroidism Medications Markets in 2022
Figure 26. United States VS China: Hyperthyroidism Medications Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Hyperthyroidism Medications Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Hyperthyroidism Medications Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 30. China Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Hyperthyroidism Medications Production Market Share 2022
Figure 32. World Hyperthyroidism Medications Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Hyperthyroidism Medications Production Value Market Share by Type in 2022
Figure 34. Methimazole
Figure 35. Propylthiouracil
Figure 36. Other
Figure 37. World Hyperthyroidism Medications Production Market Share by Type (2018-2029)
Figure 38. World Hyperthyroidism Medications Production Value Market Share by Type (2018-2029)
Figure 39. World Hyperthyroidism Medications Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Hyperthyroidism Medications Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Hyperthyroidism Medications Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Hyperthyroidism Medications Production Market Share by Application (2018-2029)
Figure 46. World Hyperthyroidism Medications Production Value Market Share by Application (2018-2029)
Figure 47. World Hyperthyroidism Medications Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Hyperthyroidism Medications Industry Chain
Figure 49. Hyperthyroidism Medications Procurement Model
Figure 50. Hyperthyroidism Medications Sales Model
Figure 51. Hyperthyroidism Medications Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
